AHL
GILD icon

Abel Hall LLC’s Gilead Sciences GILD Stock Holding History

Abel Hall LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
4,595
+1,188
+35% +$157K 0.1% 194
2026
Q1 		$475K Buy
3,407
+1,582
+87% +$222K 0.1% 208
2025
Q4 		$224K Buy
+1,825
New +$222K 0.05% 488
2025
Q2 		– Sell
-2,811
Closed -$315K – 303
2025
Q1 		$315K Sell
2,811
-652
-19% -$67.3K 0.19% 94
2024
Q4 		$320K Sell
3,463
-2,728
-44% -$246K 0.2% 84
2024
Q3 		$519K Sell
6,191
-199
-3% -$15.2K 0.34% 45
2024
Q2 		$438K Sell
6,390
-392
-6% -$26.2K 0.31% 50
2024
Q1 		$497K Buy
6,782
+1,940
+40% +$149K 0.37% 41
2023
Q4 		$392K Buy
+4,842
New +$377K 0.33% 51

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abel Hall LLC's GILD Position: Q2 2026 in Review

Abel Hall LLC increased its Gilead Sciences (GILD) stake by 35% in Q2 2026, buying an estimated $157K and bringing the position to 4,595 shares worth $581K. The position accounts for 0.1% of the portfolio, ranked #194.

Abel Hall LLC first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Abel Hall LLC held 4,595 shares of Gilead Sciences worth $581K as of Q2 2026.
  • Abel Hall LLC bought 1,188 Gilead Sciences shares in Q2 2026, an estimated $157K.
  • Gilead Sciences made up 0.1% of Abel Hall LLC's portfolio in Q2 2026, its #194 holding.
  • Abel Hall LLC first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.